Skip to main content
SpringerLink
Log in

Cannabinols

  • Chapter
Drug and Alcohol Abuse

Part of the book series: Critical Issues in Psychiatry ((CIPS))

  • 375 Accesses

Abstract

Cannabis, or marijuana, is among the most widely used of the drugs described in this text. The health-care problems involved with delta-9-tetrahydrocannabinol (THC; the key active ingredient in marijuana and in hashish) include alterations in mood, toxicity for the lungs, and impaired driving abilities with subsequent accidents. Because, as a healthcare provider, you will be called on to give information about this drug to worried parents and to teenagers attempting to make decisions about future use, this chapter presents information on the history, the physiology, and the medical effects of the cannabinols.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. O’Brien, C. P. Drug addiction and drug abuse. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 557–577.

    Google Scholar 

  2. Woody, G. E., & MacFadden, W. Cannabis-related disorders. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 810–817.

    Google Scholar 

  3. Grinspoon, L., & Bakalar, J. B. Marihuana. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 199–206

    Google Scholar 

  4. Pitts, J. E., O’Neil, P. J., & Leggo, K. P. Variation in the THC content of illicitly imported cannabis products— 1984–1989. Journal of Pharmacy and Pharmacology 42:817–820, 1990.

    Article  PubMed  Google Scholar 

  5. Liskow, B. Marijuana deterioration. Journal of the American Medical Association 214:1709, 1970.

    Article  PubMed  Google Scholar 

  6. Mathew, R. J., Wilson, W. H., & Melges, F. T. Temporal disintegration and its psychological and physiological correlates. Annals of Clinical Psychiatry 4:235–245, 1992.

    Article  Google Scholar 

  7. Pertwee, R. G. Medical uses of cannabinoids: the way forward. Addiction 94:317–320, 1999.

    Article  PubMed  Google Scholar 

  8. Schuckit, M. A. Does marijuana have any medicinal value? Vista Hill Foundation Drug Abuse & Alcoholism Newletter, 25(5), 1996.

    Google Scholar 

  9. Winger, G., Hofmann, F. G., & Woods, J. H. A handbook on drug and alcohol abuse (3rd ed.). New York: Oxford University Press, 1992, pp. 117–131.

    Google Scholar 

  10. Johansson, E., Gillespie, H. K., & Halldin, M. M. Human urinary excretion profile after smoking and oral administration of [14Cldelta1-tetrahydrocannabinol. Journal of Analytical Toxicology 14:176–180, 1990.

    PubMed  Google Scholar 

  11. Schuckit, M. A. Science, medicine, and the future: Substance use disorders. British Medical Journal 314:1605–1608, 1997.

    Article  PubMed  Google Scholar 

  12. Stein, E. A., Fuller, S. A., Edgemond, W. S., & Campbell, W. B. Selective effects of the endogenous cannabinoid arachidonylethanolamide (anandamide) on regional cerebral blood flow in the rat. Neuropsychophar-macology 19:481–491, 1998.

    Google Scholar 

  13. Cadas, H., Gaillet, S., Beltramo, M., et al. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. Journal of Neuroscience 16:3934–3942, 1996.

    PubMed  Google Scholar 

  14. Venance, L., Piomelli, D., Glowinski, J., & Glaume, C. Inhibition by anadamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature 376:590–593, 1995.

    Article  PubMed  Google Scholar 

  15. Tanda, G., Pontieri, F. E., & DiChiara, G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common ul opioid receptor mechanism. Science 276:2048–2050, 1997.

    Article  PubMed  Google Scholar 

  16. Gifford, A. N., Gardner, E. L., & Ashby, C. R. The effect of intravenous administration of delta-9-tetrahy-drocannabinol on the activity of A10 dopamine neurons in vivo in anesthetized rats. Neuropsychology 36:96–99, 1997.

    Google Scholar 

  17. Jentsch, D. J., Andrusiak, E., Tran, A., et al. Δ9-tetrahydrocannabinol increases prefrontal cortical cate-cholaminergic utilization and impairs spatial working memory in the rat: Blockade of dopaminergic effects with HA966. Neuropsychopharmacology 16:426–432, 1997.

    Article  PubMed  Google Scholar 

  18. Sethi, B. G. B., Trivedi, J. K., Kumar, P., et al. Antianxiety effect of cannabis: Involvement of central benzodiazepine receptors. Biological Psychiatry 21:3–10, 1986.

    Article  PubMed  Google Scholar 

  19. Mathew, R. J., Wilson, W. H., Humphreys, D., et al. Depersonalization after marijuana smoking. Biological Psychiatry 33:431–441, 1993.

    Article  PubMed  Google Scholar 

  20. Chesher, G. B., Bird, K. D., Jackson, D. M., et al. The effects of orally administered ΔA9-tetrahydrocannabinol in man on mood and performance measures: A dose-response study. Pharmacology Biochemistry & behavior 35:861–864, 1990.

    Article  Google Scholar 

  21. Mathew, R. J., Wilson, W. H., Humphreys, D. F., et al. Changes in middle cerebral artery velocity after marijuana. Biological Psychiatry 32:164–169, 1992.

    Article  PubMed  Google Scholar 

  22. Feeney, D. M. Marihuana and epilepsy. Science 197:1301–1302, 1977.

    PubMed  Google Scholar 

  23. Gottschalk, L. A., Aronow, W. S., & Prakash, R. Effect of marijuana and placebo-marijuana smoking on psychological state and on psychophysiological cardiovascular functioning in anginal patients. Biological Psychiatry 12:255–266, 1977.

    PubMed  Google Scholar 

  24. American Psychiatric Association. The diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Press, 1994.

    Google Scholar 

  25. Gold, M. S. Marijuana. In N. S. Miller (Ed.), Comprehensive handbook of drug and alcohol addiction. New York: Marcel Dekker, 1991, pp. 353–382.

    Google Scholar 

  26. Wiesbeck, G. A., Schuckit, M. A., Kalmijn, J. A., et al. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction 91:1469–1478, 1996.

    Article  PubMed  Google Scholar 

  27. Schuckit, M. A. Is there a clinically significant marijuana withdrawal syndrome? Vista Hill Foundation Drug Abuse & Alcoholism Newsletter, 24(2), 1995.

    Google Scholar 

  28. Crowley, T. J., Macdonald, B. S., Whitmore, E. A., & Mikulich, S. K. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug and Alcohol Dependence 50:27–37, 1998.

    Article  PubMed  Google Scholar 

  29. Mendelson, J. H., Mello, N. K., Lex, B. W., & Bavli, S. Marijuana withdrawal syndrome in a woman. American Journal of Psychiatry 141:1289–1290, 1984.

    PubMed  Google Scholar 

  30. Kendler, K. S., & Prescott, C. A. Cannabis use, abuse, and dependence in a population-based sample of female twins. American Journal of Psychiatry 155:1016–1022, 1998.

    PubMed  Google Scholar 

  31. Lyons, M. J., Toomey, R., Meyer, J. M., et al. How do genes influence marijuana use? The role of subjective effects. Addiction 92:409–417, 1997.

    Article  PubMed  Google Scholar 

  32. Schuckit, M. A. Biological, psychological and environmental predictors of the alcoholism risk: A longitudinal study. Journal of Studies on Alcohol 59:485–494, 1998.

    PubMed  Google Scholar 

  33. Schuckit, M. A., & Smith, T. L. An 8-year follow-up of 450 sons of alcoholic and control subjects. Archives of General Psychiatry 53:202–210, 1996.

    Article  PubMed  Google Scholar 

  34. Bachman, J. G., Johnston, L. D., & O’Malley, P. M. Explaining recent increases in students’ marijuana use: impacts of perceived risks and disapproval, 1976 through 1996. American Journal of Public Health 88:887–892, 1998.

    Article  PubMed  Google Scholar 

  35. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Household Survey on drug abuse: Population estimates 1997. Rockville, MD: U.S. Department of Health and Human Services, 1998.

    Google Scholar 

  36. Hammer, T., & Vaglum, P. Initiation, continuation, or discontinuation of cannabis use in the general population. British Journal of Addiction 85:899–909, 1990.

    Article  PubMed  Google Scholar 

  37. Johnston, L. D., O’Malley, P. M., & Bachman, J. G. National survey results on drug use from the Monitoring the Future Study, 1975–1997, Vol. I, Secondary School Students. Rockville, MD: National Institute on Drug Abuse, U.S. Department of Health and Human Services, 1998.

    Google Scholar 

  38. Bell, R., Wechsler, H., & Johnston, L. D. Correlates of college student marijuana use: Results of a U.S. national survey. Addiction 92:571–581, 1997.

    Article  PubMed  Google Scholar 

  39. Silva, M. T., Barros, R. S., & de Maglhães, M. P. Use of marijuana and other drugs by college students of São Paulo, Brazil. International Journal of Addictions 29:1045–1056, 1994.

    Google Scholar 

  40. Royo-Bordonada, M. A., Cid-Ruzafa, J., Martin-Morena, J. M., & Guallar, E. Drug and alcohol use in Spain: Consumption habits, attitudes and opinions. Public Health 111:277–284, 1997.

    PubMed  Google Scholar 

  41. Mora, M. E., Villatoro, J., & Rojas, E. Drug use among students in Mexico’s northern border states. In Department of Health and Human Services, Epidemiologic trends in drug abuse. Washington, DC: U.S. Government Printing Office, 1996, pp. 367–375.

    Google Scholar 

  42. Reilly, D., Didcott, P., Swift, W., & Hall, W. Long-term cannabis use: Characteristics of users in an Australian rural area. Addiction 93:837–846, 1998.

    Article  PubMed  Google Scholar 

  43. Forster, L. M., Tannhauser, M., & Barros, H. M. Drug use among street children in southern Brazil. Drug and Alcohol Dependence 43:57–62, 1996.

    Article  PubMed  Google Scholar 

  44. Kandel, D. B., & Raveis, V. H. Cessation of illicit drug use in young adulthood. Archives of General Psychiatry 46:109–116, 1989.

    Article  PubMed  Google Scholar 

  45. Kandel, D. B., Davies, K., Karus, D., & Yamaguchi, K. The consequences in young adulthood of adolescent drug involvement. Archives of General Psychiatry 43:746–754, 1986.

    Article  PubMed  Google Scholar 

  46. Mathers, D. C., Ghodse, A. H., Caan, A. W., & Scott, S. A. Cannabis use in a large sample of acute psychiatric admissions. British Journal of Addiction 86:779–784, 1991.

    Article  PubMed  Google Scholar 

  47. Swift, W., Hall, W., Didcott, P., & Reilly, D. Patterns and correlates of cannabis dependence among long-term users in an Australian rural area. Addiction 93:1149–1160, 1998.

    Article  PubMed  Google Scholar 

  48. Hall, W., & Solowij, N. Long-term cannabis use and mental health. British Journal of Psychiatry 171:107–108, 1997.

    Article  PubMed  Google Scholar 

  49. Rodroguez de Fonseca, F., Carrera, M. R. A., Navarro, M., et al. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276:2050–2054, 1997.

    Article  Google Scholar 

  50. Sidney, S., Beck, J. E., Tekawa, I. S., et al. Marijuana and mortality. The American Journal of Public Health 87:585–590, 1997.

    Article  Google Scholar 

  51. British Medical Association. Therapeutic uses of cannabis. Amsterdam: Harwood Academic Publishers, 1997.

    Google Scholar 

  52. Whitfield, R. M., Bechtel, L. M., & Starich, G. H. The impact of ethanol and marinol marijuana usage on HIV+/AIDS patients undergoing azidothymidine, azidothymidine/dideoxycytidine, or dideoxyinosine therapy. Alcoholism: Clinical and Experimental Research 21:122–127, 1997.

    Article  Google Scholar 

  53. Rose, M. Cannabis: A medical question? Lancet 1:703, 1980.

    PubMed  Google Scholar 

  54. Chaudry, H. R., Moss, H. B., Bashir, A., & Suliman, T. Cannabis psychosis following bhang ingestion. British Journal of Addiction 86:1075–1081, 1991.

    Article  PubMed  Google Scholar 

  55. Allebeck, P., Adamsson, C., Engström, A., & Rydberg, U. Cannabis and schizophrenia: A longitudinal study of cases treated in Stockholm County. Acta Psychiatrica Scandinavica 88:21–24, 1993.

    Article  PubMed  Google Scholar 

  56. Imade, A. G. T., & Ebie, J. C. A retrospective study of symptom patterns of cannabis-induced psychosis. Acta Psychiatrica Scandinavica 83:134–136, 1991.

    Article  PubMed  Google Scholar 

  57. Leweke, F M., Giuffrida, A., Wurster, U., et al. Elevated endogenous cannabinoids in schizophrenia. NeuroReport 10:1665–1669, 1999.

    Article  PubMed  Google Scholar 

  58. Caspari, D. Cannabis and schizophrenia: results of a follow-up study. European Archives of Psychiatry and Clinical Neuroscience 249:45–49, 1999.

    Article  PubMed  Google Scholar 

  59. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Geneva: World Health Organization, 1992.

    Google Scholar 

  60. Leweke, M., Kampmann, C., Radwan, M., et al. The effects of tetrahydrocannabinol on the recognition of emotionally charged words: An analysis using event-related brain potentials. Neuropsychobiology 37:104–111, 1998.

    Article  PubMed  Google Scholar 

  61. Solowij, N., Michie, P. T., & Fox, A. M. Differential impairments of selective attention due to frequency and duration of cannabis use. Biological Psychiatry 37:731–739, 1995.

    Article  PubMed  Google Scholar 

  62. Deahl, M. Cannabis and memory loss. British Journal of Addiction 86:249–252, 1991.

    Article  PubMed  Google Scholar 

  63. Block, R. I., & Ghoneim, M. M. Effects of chronic marijuana use on human cognition. Psychopharmacology 110:219–228, 1993.

    Article  PubMed  Google Scholar 

  64. Fletcher, J. M., Page, B., Francis, D. J., et al. Cognitive correlates of long-term cannabis use in Costa Rica men. Archives of General Psychiatry 53:1051–1057, 1996.

    Article  PubMed  Google Scholar 

  65. Pope, H. G., Jr., & Yurgelun-Todd, D. The residual cognitive effects of heavy marijuana use in college students. Journal of American Medical Association 275:521–527, 1996.

    Article  Google Scholar 

  66. Patrick, G. Straumanis, J. J., Struve, F A. et al. Reduced P50 auditory gating response in psychiatrically norman chronic marihuana users: A pilot study. Biological Psychiatry 45:1307–1312, 1999.

    Article  PubMed  Google Scholar 

  67. Brook, J. S., Gordon, A. S., Brook, A., & Brook, D. W. The consequences of marijuana use on intrapersonal and interpersonal functioning in black and white adolescents. Genetic, Social, and General Psychology Monographs 115:349–369, 1990.

    Google Scholar 

  68. Andreasson, S., Allebeck, P., Engstrom, A., & Rydberg, U. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet 2:1483–1486, 1987.

    Article  PubMed  Google Scholar 

  69. Goodwin, D. W., & Guze, S. B. Psychiatric Diagnosis (5th ed.). New York: Oxford University Press, 1996.

    Google Scholar 

  70. Troisi, A., Pasini, A., Saracco, M., & Spalletta, G. Psychiatric symptoms in male cannabis users not using other illicit drugs. Addiction 93:487–492, 1998.

    Article  PubMed  Google Scholar 

  71. Hall, W. The respiratory risks of cannabis smoking. Addiction 93:1461–1463, 1998.

    Article  PubMed  Google Scholar 

  72. Feldman, A. L., Sullivan, J. T., Passero, M. A., & Lewis, D. C. Pneumothorax in polysubstance-abusing marijuana and tobacco smokers: Three cases. Journal of Substance Abuse 5:183–186, 1993.

    Article  PubMed  Google Scholar 

  73. Dax, E. M., Pilotte, N. S., Adler, W. H., et al. The effects of 9-one-tetrahydrocannabinol on hormone release and immune function. Journal of Steroid Biochemistry 34:263–270, 1989.

    Article  PubMed  Google Scholar 

  74. Taylor, D. N., Washsmuth, I. K., Shangkuan, Y. H., et al. Salmonellosis associated with marijuana: A multistate outbreak traced by plasmid fingerprinting. New England Journal of Medicine 306:1249–1253, 1982.

    Article  PubMed  Google Scholar 

  75. Zimmerman, S., & Zimmerman, A. M. Genetic effects of marijuana. International Journal of the Addictions 25:19–33, 1991.

    Google Scholar 

  76. Robins, L. N., & Mus, J. L. Effects of in utero exposure to street drugs. American Journal of Public Health, Supplement to Vol. 83, 1993.

    Google Scholar 

  77. Zuckerman, B., Frank, D. A., Hingson, R., et al. Effects of maternal marijuana and cocaine use on fetal growth. New England Journal of Medicine 320:762–768, 1989.

    Article  PubMed  Google Scholar 

  78. Smith, C. G., & Asch, R. H. Drug abuse and reproduction. Fertility and Sterility 48:355–373, 1987.

    PubMed  Google Scholar 

  79. Block, R. I., Farinpour, R., & Schlechte, J. A. Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin, and Cortisol in men and women. Drug and Alcohol Dependence 28:121–128, 1991.

    Article  PubMed  Google Scholar 

  80. Murphy, L. L., Muñoz, R. M., Adrian, B. A., & Villanúa, M. A. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiology of Disease 5:432–446, 1998.

    Article  PubMed  Google Scholar 

  81. Bier, M. M., & Steahly, L. P. Emergency treatment of marihuana complicating diabetes. In P. G. Bourne (Ed.), A treatment manual for acute drug abuse emergencies. Washington, DC: U.S. Government Printing Office, 1974, pp. 88–94.

    Google Scholar 

  82. Lukas, S. E., Benedikt, R., Mendelson, J. H., et al. Marihuana attenuates the rise in plasma ethanol levels in human subjects. Neuropsychopharmacology 7:77–81, 1992.

    PubMed  Google Scholar 

  83. Kurzthaler, I., Hummer, M., Miller, C., et al. Effect of cannabis use on cognitive functions and driving ability. Journal of Clinical Psychiatry 60:395–399, 1999.

    Article  PubMed  Google Scholar 

  84. Yesavage, J. A., Leirer, V. O., Denari, M., & Hollister, L. E. Carryover effects of marijuana intoxication on aircraft pilot performance: A preliminary report. American Journal of Psychiatry 142:1325–1329, 1985.

    PubMed  Google Scholar 

  85. Liguori, A., Gatto, C. P., & Robinson, J. H. Effects of marijuana on equilibrium, psychomotor performance, and simulated driving. Behavioural Pharmacology 9:599–609, 1998.

    Article  PubMed  Google Scholar 

  86. Schuckit, M. A. Educating yourself about alcohol and drugs. New York: Plenum Publishing Co., 1998.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of California Medical School and Veterans Affairs San Diego Healthcare System, San Diego, California, USA

    Marc A. Schuckit M. D. (Professor of Psychiatry)

Authors
  1. Marc A. Schuckit M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schuckit, M.A. (2000). Cannabinols. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3232-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3232-0_7

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-3234-4

  • Online ISBN: 978-1-4757-3232-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation